How to manage a patient with uncontrolled hypertension who was previously taking lisinopril?

Management of Uncontrolled Hypertension in a Patient Previously on Lisinopril

Immediate Action Required

Restart combination antihypertensive therapy immediately with a two-drug regimen, preferably using a single-pill combination of an ACE inhibitor (or ARB) plus either a calcium channel blocker or thiazide-like diuretic, as monotherapy achieves target BP (<140/90 mmHg) in only 20-30% of patients. 1

---

Step-by-Step Management Algorithm

1. Confirm the Diagnosis

• Verify the elevated BP reading with out-of-office measurements (home BP monitoring or ambulatory BP monitoring) before intensifying therapy, as white coat hypertension affects approximately 50% of apparent resistant cases 1
• Home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg confirms true hypertension 2
• The single office reading of 159/105 mmHg represents stage 2 hypertension if confirmed 1

2. Assess Why Lisinopril Was Discontinued

• Determine if the patient stopped lisinopril due to side effects (cough, angioedema, hyperkalemia) or simply non-adherence 1
• If discontinued due to cough (10-15% of patients), switch to an ARB rather than restarting an ACE inhibitor 1
• If discontinued due to angioedema (absolute contraindication), avoid all ACE inhibitors and ARBs 1
• If stopped due to non-adherence or cost, address these barriers and consider restarting 1

3. Initiate Combination Therapy (Preferred Approach)

For most patients with BP 159/105 mmHg, start with two-drug combination therapy rather than monotherapy, as this achieves BP control more rapidly and effectively 1

Preferred Two-Drug Combinations:

• ACE inhibitor (or ARB) + calcium channel blocker (amlodipine 5-10mg) 1

  • This combination provides complementary mechanisms: vasodilation plus renin-angiotensin system blockade 2
  • Particularly beneficial if the patient has diabetes, chronic kidney disease, or coronary artery disease 2

• ACE inhibitor (or ARB) + thiazide-like diuretic (chlorthalidone 12.5-25mg or indapamide 1.25-2.5mg) 1

  • Chlorthalidone preferred over hydrochlorothiazide due to longer duration of action 2
  • More effective in Black patients and elderly patients 2

Specific Dosing Recommendations:

• If restarting lisinopril: Begin with lisinopril 10-20mg once daily (not the previous dose if unknown) 3, 4
• If switching to ARB: Start with losartan 50mg or valsartan 80mg once daily 1
• Use fixed-dose single-pill combinations to improve adherence 1

4. Concurrent Lifestyle Modifications

Initiate lifestyle interventions simultaneously with pharmacotherapy (not sequentially), as these provide additive BP reductions of 10-20 mmHg 1, 2:

• Sodium restriction to <2g/day 1
• Weight management (target BMI 20-25 kg/m²) 1
• Regular aerobic exercise 1
• Alcohol limitation to <100g/week 1
• Smoking cessation if applicable 1

5. Monitoring and Titration Schedule

• Reassess BP within 2-4 weeks after initiating therapy 2
• Target BP: 120-129 mmHg systolic if well tolerated, or at minimum <140/90 mmHg 1
• Check serum potassium and creatinine 2-4 weeks after starting ACE inhibitor/ARB to detect hyperkalemia or acute kidney injury 2

6. If BP Remains Uncontrolled on Two Drugs

Escalate to triple therapy with ACE inhibitor/ARB + calcium channel blocker + thiazide-like diuretic, preferably as a single-pill combination 1:

• This represents the guideline-recommended approach for uncontrolled hypertension 1
• Optimize doses of all three agents before adding a fourth drug 1, 2

7. Resistant Hypertension (If BP Uncontrolled on Three Drugs)

Before adding a fourth agent, exclude pseudoresistance 1:

• Poor BP measurement technique
• White coat effect
• Non-adherence (most common cause)
• Suboptimal drug choices or doses
• Substance-induced hypertension (NSAIDs, decongestants, alcohol)

If true resistant hypertension confirmed, add spironolactone 25-50mg daily as the preferred fourth-line agent, provided serum potassium <4.5 mmol/L and eGFR >45 ml/min/1.73m² 1

---

Critical Pitfalls to Avoid

• Do not restart lisinopril as monotherapy for BP 159/105 mmHg, as monotherapy achieves target BP in only 20-30% of patients with this degree of elevation 1
• Do not combine two RAS blockers (ACE inhibitor + ARB), as this increases adverse events without additional benefit 1
• Do not add a beta-blocker unless there are compelling indications (angina, post-MI, heart failure with reduced ejection fraction, or tachyarrhythmias) 1
• Do not delay treatment intensification in stage 2 hypertension, as this increases cardiovascular risk 2
• Do not assume treatment failure without first confirming medication adherence 1, 2

---

Special Considerations

If Patient Has Chronic Kidney Disease:

• Start with lower doses: lisinopril 2.5-5mg if GFR <30 ml/min 3, 4
• Monitor creatinine closely; a 30% increase in creatinine after starting ACE inhibitor/ARB is acceptable and does not indicate true tubular injury 1
• Use loop diuretics instead of thiazides if eGFR <30 ml/min/1.73m² 1

If Patient is Elderly (≥65 years):

• Start with lisinopril 5-10mg daily 5
• Monitor for orthostatic hypotension 1
• Consider starting with monotherapy if age ≥85 years, moderate-to-severe frailty, or symptomatic orthostatic hypotension 1

If Patient is Black:

• Calcium channel blocker + thiazide diuretic may be more effective than ACE inhibitor/ARB-based combinations 2
• However, ACE inhibitor/ARB still appropriate if compelling indications exist (diabetes, CKD, heart failure) 1